Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Pediatric Gastroenterology and Nutrition"
DOI: 10.1097/mpg.0000000000003404
Abstract: ABSTRACT Hepatic involvement in coronavirus disease 2019 (COVID-19) is typically characterized as mild hepatitis with preserved synthetic function in children. Severe hepatitis is a rare complication of COVID-19 infection that has not been extensively described…
read more here.
Keywords:
coronavirus disease;
covid;
hepatitis;
disease 2019 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1164236
Abstract: Pembrolizumab, an anti-programmed death-1 (PD-1) receptor monoclonal antibody, is an effective first-line therapy for metastatic head and neck squamous cell carcinoma. Immune-related adverse events (irAEs) are well-described complications of PD-1 inhibitors, and multiorgan irAEs are…
read more here.
Keywords:
cell carcinoma;
delayed severe;
squamous cell;
gastritis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1062408
Abstract: During the first half of 2022, the World Health Organization reported an outbreak of acute severe hepatitis of unknown aetiology (AS-Hep-UA) in children, following initial alerts from the United Kingdom (UK) where a cluster of…
read more here.
Keywords:
hepatitis outbreak;
outbreak children;
pathology;
acute severe ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Bioscience trends"
DOI: 10.5582/bst.2022.01438
Abstract: Recently, the morbidity of acute severe hepatitis of unknown origin in children (SHIC) has tended to decrease, but this condition should not be ignored because of its uncertain but severe nature. The current study briefly…
read more here.
Keywords:
information;
unknown origin;
origin children;
acute severe ... See more keywords